Moderna MRNA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $389M+260% | $678M-29.8% | $1.02B-45.4% | $142M-41.1% | $108M-35.3% | ||
| $955M+961% | $452M-38.8% | $207M-59.7% | $119M+3.5% | $90M-6.3% | ||
| -$566M-3,244% | $226M-0.4% | $809M-40.0% | $23M-81.7% | $18M-74.6% | ||
| -145.5%-162pp | 33.3%+9.8pp | 79.6%+7.2pp | 16.2%-36.1pp | 16.7%-25.8pp | ||
| $649M-24.2% | $775M-30.9% | $801M-29.6% | $700M-42.7% | $856M-19.5% | ||
| $173M-18.4% | $308M-12.3% | $268M-4.6% | $230M-14.2% | $212M-22.6% | ||
| $1.78B+53.5% | $1.54B-30.6% | $1.28B-34.0% | $1.05B-34.6% | $1.16B-19.2% | ||
| -$1.39B-32.2% | -$857M+31.2% | -$260M-271% | -$907M+33.5% | -$1.05B+17.1% | ||
| -356.8%+615pp | -126.4%+2.6pp | -25.6%-21.8pp | -638.7%-73.2pp | -972.2%-214pp | ||
| $72M-20.0% | $70M-23.1% | $73M-29.1% | $81M-27.0% | $90M-25.0% | ||
| -$18M-350% | -$12M+58.6% | $0+100% | $8M+130% | -$4M+78.9% | ||
| -$1.33B-38.4% | -$799M+32.5% | -$187M-990% | -$818M+36.0% | -$964M+17.3% | ||
| $9M+28.6% | $27M+142% | $13M+62.5% | $7M— | $7M-30.0% | ||
| -$1.34B-38.3% | -$826M+26.3% | -$200M-1,638% | -$825M+35.5% | -$971M+17.4% | ||
| -345.2%+554pp | -121.8%-5.9pp | -19.7%-20.4pp | -581%-50.3pp | -899.1%-195pp | ||
| -$3.40-34.9% | -$2.11+27.5% | -$0.51-1,800% | -$2.13+36.0% | -$2.52+17.9% | ||
| -$3.40-34.9% | -$2.11+27.5% | -$0.51-1,800% | -$2.13+36.0% | -$2.52+17.9% | ||
| 395M+2.3% | 389M+1.3% | 390M-2.3% | 388M+1.0% | 386M+1.0% | ||
| 395M+2.3% | 389M+1.3% | 390M+1.3% | 388M+1.0% | 386M+1.0% | ||
| -$18M-350% | -$12M+58.6% | $0+100% | $8M+130% | -$4M+78.9% | ||
| $389M+260% | $678M-29.8% | $1.02B-45.4% | $142M-41.1% | $108M-35.3% | ||
| -$1.33B-31.5% | -$790M+33.4% | -$208M-1,056% | -$850M+35.7% | -$1.01B+17.8% | ||
| -341.6%+594pp | -116.5%+6.3pp | -20.5%-19.5pp | -598.6%-50.0pp | -936.1%-200pp | ||
| -$1.39B-32.2% | -$857M+31.2% | -$260M-271% | -$907M+33.5% | -$1.05B+17.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Moderna's revenue?
- Moderna (MRNA) generated $2.2B in revenue over the trailing twelve months, down 30.0% year over year.
- Is Moderna profitable?
- Moderna is not currently profitable: it reported a net loss of $3.2B over the trailing twelve months, a -143.6% net margin.
- What are Moderna's profit margins?
- Gross margin is 22.1% and operating margin is -153.3%, with a -143.6% net margin.
- What is Moderna's earnings per share?
- Moderna's diluted EPS over the trailing twelve months is $-8.15.
- Where does Moderna's income statement data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
